Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) per Share (Tables)

v3.23.3
Net Income (Loss) per Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Income (Loss) per Share [Abstract]  
Computation of Weighted Average Common Shares
The following table presents the computation of weighted average common shares considered in the computation of diluted net income (loss) per share during the periods presented:

 
 
Three Months
Ended
September 30,
   
Nine Months
Ended
September 30,
 
 
 
2023
   
2022
   
2023
   
2022
 
Basic
   
21,446,648
     
20,498,229
     
21,117,211
     
19,635,651
 
Dilutive stock options
   
914,583
     
     
     
 
Dilutive RSUs
   
44,764
     
     
     
 
Dilutive warrants
   
     
     
     
 
Diluted common shares outstanding
   
22,405,995
     
20,498,229
     
21,117,211
     
19,635,651
 
Anti-dilutive Securities Excluded from Computation of Net Income (Loss) per Share

The following potential common shares were not considered in the computation of diluted net income (loss) per share as their effect would have been anti-dilutive for the three and nine-month periods presented below:
 
   
Three Months
Ended
September 30,
   
Nine Months
Ended
September 30,
 
   
2023
   
2022
    2023     2022  
Series A, Series B, and RDO warrants
   
7,204,299
     
7,281,977
      7,204,299       7,281,977  
Stock options
   
2,554,806
     
2,938,044
      3,469,389       2,938,044  
RSUs     237,244             282,008        
Former Rexahn warrants
   
58,597
     
63,734
      58,597       63,734